Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

DNTHDNTH
10 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in Dianthus Therapeutics, Inc.

RA CAPITAL MANAGEMENT, L.P. previously held 0 shares of DNTH (Dianthus Therapeutics, Inc.), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$70M

Total Shares Change

-2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$97.48
0
2026-Q1
Increased
2.6M
+62.0%
$219.2M2.3%$55.39
76
2025-Q4
Decreased
1.6M
-43.8%
$66.4M0.7%$40.96
0
2025-Q3
Unchanged
2.9M
0.0%
$112.8M1.4%$39.55
0
2025-Q2
Unchanged
2.9M
0.0%
$53.4M0.9%$17.63
0
2025-Q1
Increased
2.9M
+53.6%
$52M0.9%$19.99
58
2024-Q4
Decreased
1.9M
-20.0%
$40.7M0.5%$21.50
0
2024-Q3
Unchanged
2.3M
0.0%
$63.9M0.7%$27.24
0
2024-Q2
Unchanged
2.3M
0.0%
$60.4M0.8%$25.88
0
2024-Q1
New
2.3M
-
$70M0.9%$30.00
58

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used